Literature DB >> 20919419

The in vitro and in vivo Antibacterial Activity of Cefuroxime.

S Goto.   

Abstract

Entities:  

Year:  1977        PMID： 20919419      PMCID： PMC1543250     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  8 in total

1.  Cefuroxime, a new parenteral cephalosporin: collaborative in vitro susceptibility comparison with cephalothin against 5,887 clinical bacterial isolates.

Authors:  R N Jones; P C Fuchs; T L Gavan; E H Gerlach; A L Barry; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

2.  Cefuroxime - a new cephalosporin antibiotic.

Authors:  C H O'Callaghan; R B Sykes; D M Ryan; R D Foord; P W Muggleton
Journal:  J Antibiot (Tokyo)       Date:  1976-01       Impact factor: 2.649

3.  Cefuroxime: a new cephalosporin antibiotic with enhanced stability to enterobacterial beta-lactamases.

Authors:  D Greenwood; N J Pearson; F O'Grady
Journal:  J Antimicrob Chemother       Date:  1976-12       Impact factor: 5.790

4.  Comparative study of the in vitro antibacterial activity of cefoxitin, cefuroxine, and cephaloridine.

Authors:  R Norrby; J E Brorsson; S Seeberg
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

5.  Cefuroxime, a new cephalosporin antibiotic: activity in vivo.

Authors:  D M Ryan; C O'Callaghan; P W Muggleton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

6.  Cefuroxime, a new cephalosporin antibiotic: activity in vitro.

Authors:  C H O'Callaghan; R B Sykes; A Griffiths; J E Thornton
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

7.  Antibacterial activity of cefuroxime, a new cephalosporin antibiotic, compared with that of cephaloridine, cephalothin, and cefamandole.

Authors:  S Eykyn; C Jenkins; A King; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

8.  Comparative study of seven cephalosporins: susceptibility to beta-lactamases and ability to penetrate the surface layers of Escherichia coli.

Authors:  M H Richmond; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191
  8 in total
  5 in total

1.  Perioperative antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative trial of cefazolin versus ceftriaxone.

Authors:  M Soteriou; F Recker; S Geroulanos; M Turina
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

Review 2.  Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

Review 3.  Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-01       Impact factor: 9.546

4.  Physiologically based pharmacokinetic evaluation of cefuroxime in perioperative antibiotic prophylaxis.

Authors:  Christer Rimmler; Christian Lanckohr; Ceren Akamp; Dagmar Horn; Manfred Fobker; Karsten Wiebe; Bassam Redwan; Bjoern Ellger; Robin Koeck; Georg Hempel
Journal:  Br J Clin Pharmacol       Date:  2019-12-15       Impact factor: 4.335

Review 5.  The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition.

Authors:  Jonathan Turner; Alyssa Muraoka; Michael Bedenbaugh; Blaine Childress; Lauren Pernot; Mark Wiencek; Yuri K Peterson
Journal:  Front Microbiol       Date:  2022-03-24       Impact factor: 5.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.